FONAR Corp. Files Q2 Fiscal 2025 10-Q
Ticker: FONR · Form: 10-Q · Filed: Feb 19, 2025 · CIK: 355019
Sentiment: neutral
Topics: 10-Q, quarterly-report, medical-devices
TL;DR
FONAR filed its Q2 FY25 10-Q. Financials are in.
AI Summary
FONAR Corp. filed its 10-Q for the period ending December 31, 2024. The company, based in Melville, NY, operates in the electromedical and electrotherapeutic apparatus industry. This filing covers the second quarter of their fiscal year 2025, providing financial updates and operational details.
Why It Matters
This filing provides investors with the latest financial performance and operational status of FONAR Corp., crucial for understanding the company's health and future prospects in the medical device sector.
Risk Assessment
Risk Level: low — The filing is a routine quarterly report and does not indicate any immediate or significant new risks.
Key Numbers
- Q2 2025 — Fiscal Quarter (Reporting period for the 10-Q filing.)
- 2024-12-31 — End of Reporting Period (The date through which financial information is reported.)
Key Players & Entities
- FONAR CORP (company) — Filer
- Melville, NY (location) — Business Address
- 3845 (industry_code) — Standard Industrial Classification
- 2024-12-31 (date) — Period of Report
- 2025-02-19 (date) — Filed as of Date
FAQ
What is the primary business of FONAR Corp?
FONAR Corp. is involved in the electromedical and electrotherapeutic apparatus industry, as indicated by its SIC code 3845.
For which fiscal period is this 10-Q filing?
This 10-Q filing is for the period ending December 31, 2024, which corresponds to the second quarter of fiscal year 2025.
Where is FONAR Corp. headquartered?
FONAR Corp. is located at 110 Marcus Drive, Melville, NY 11747.
When was this 10-Q filing submitted?
The filing was submitted on February 19, 2025.
What is the SEC file number for FONAR Corp?
The SEC file number for FONAR Corp. is 000-10248.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on February 19, 2025 regarding FONAR CORP (FONR).